National Health Investors, Inc. NHI
- Market cap
- $3.3B
- P/E
- 19.3×
Follow NHI
Target Price Range
Analyst price targets
Free account| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 54.51 | 68.96 | 62.71 | 73.35 | 31.37 | 50.88 | 50.22 | 47.54 | 51.59 | 65.13 |
Analyst estimates 2026–2028 Powerpack |
Low Price
|
||
| 82.53 | 81.60 | 81.56 | 86.54 | 91.12 | 78.56 | 67.16 | 60.17 | 86.13 | 80.56 |
High Price
|
|||
| — | — | — | — | — | — | 27 | 26 | 30 | 32 |
Employees
|
|||
| 0 | 0 | 0 | 0 | 0 | 0 | 10 | 12 | 11 | 12 |
Revenue/Emp
|
|||
| 248 | 279 | 295 | 318 | 333 | 299 | 278 | 320 | 335 | 376 |
Revenue
|
|||
| 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 89.87% | 87.62% | 87.39% | 83.78% |
Gross Margin
|
|||
| 153 | 159 | 154 | 160 | 185 | 112 | 66 | 134 | 137 | 141 |
EBT
|
|||
| 61.47% | 57.19% | 52.39% | 50.44% | 55.68% | 37.48% | 23.55% | 42.02% | 40.77% | 37.48% |
EBT Margin
|
|||
| 153 | 159 | 154 | 160 | 185 | 112 | 66 | 134 | 137 | 141 |
Net Income
|
|||
| 62 | 73 | 76 | 82 | 89 | 85 | 82 | 75 | 78 | 86 |
Depreciation
|
|||
| 6.37 | 6.81 | 7.02 | 7.33 | 7.45 | 6.53 | 6.21 | 7.37 | 7.64 | 8.01 |
Revenue/Sh
|
|||
| 3.88 | 3.90 | 3.68 | 3.70 | 4.14 | 2.45 | 1.48 | 3.13 | 3.14 | 3.03 |
Earnings/Sh
|
|||
| 4.53 | 4.84 | 4.96 | 5.55 | 5.19 | 4.61 | 4.14 | 4.25 | 4.74 | 5.05 |
Cash Flow/Sh
|
|||
| (9.41) | (4.29) | (3.52) | (5.46) | (1.72) | 4.12 | 3.53 | 0.17 | (3.46) | (6.27) |
Capex/Sh
|
|||
| (4.88) | 0.56 | 1.44 | 0.09 | 3.47 | 8.74 | 7.67 | 4.42 | 1.28 | (1.23) |
Free CF/Sh
|
|||
| 31.00 | 32.33 | 33.13 | 34.51 | 34.07 | 33.18 | 28.59 | 29.14 | 31.37 | 32.63 |
Book Value/Sh
|
|||
| 39 | 41 | 42 | 43 | 45 | 46 | 45 | 43 | 44 | 47 |
Shares
|
|||
| 19.22 | 19.43 | 20.47 | 22.14 | 16.71 | 23.55 | 35.94 | 17.79 | 22.07 | 25.20 |
PE Ratio
|
|||
| 11.71 | 11.12 | 10.75 | 11.12 | 9.29 | 8.80 | 8.50 | 7.55 | 9.07 | 9.53 |
PS Ratio
|
|||
| 2.41 | 2.34 | 2.28 | 2.36 | 2.03 | 1.73 | 1.85 | 1.91 | 2.21 | 2.34 |
PB Ratio
|
|||
| 16.18 | 15.22 | 15.09 | 15.63 | 13.66 | 12.83 | 12.56 | 11.03 | 12.41 | 12.58 |
EV/Sales
|
|||
| (21.12) | 186.42 | 73.82 | 1,319.43 | 29.33 | 9.60 | 10.18 | 18.38 | 74.27 | (82.20) |
EV/FCF
|
|||
| 177 | 198 | 208 | 241 | 232 | 211 | 185 | 184 | 208 | 237 |
Op' Cash Flow
|
|||
| (367) | (175) | (148) | (237) | (77) | 189 | 158 | 7 | (152) | (294) |
Capex
|
|||
| (190) | 23 | 60 | 4 | 155 | 399 | 343 | 192 | 56 | (57) |
FCF
|
|||
| 190 | 226 | 337 | 405 | 406 | 410 | 303 | 318 | 343 | 258 |
Working Cap'
|
|||
| 1,116 | 1,145 | 1,282 | 1,440 | 1,499 | 1,243 | 1,148 | 1,135 | 1,146 | 1,164 |
Total Debt
|
|||
| 1,111 | 1,142 | 1,277 | 1,435 | 1,456 | 1,205 | 1,128 | 1,113 | 1,122 | 1,144 |
Net Debt
|
|||
| 1,210 | 1,322 | 1,390 | 1,498 | 1,523 | 1,517 | 1,280 | 1,264 | 1,375 | 1,530 |
Sh' Equity
|
|||
| 6.68% | 6.44% | 5.83% | 5.54% | 6.01% | 3.75% | 2.48% | 5.43% | 5.40% | 5.25% |
ROA
|
|||
| 4.36% | 5.02% | 4.78% | 4.64% | 4.70% | 3.06% | 2.11% | 4.66% | 4.59% | 4.57% |
ROIC
|
|||
| 12.89% | 12.59% | 11.38% | 11.11% | 12.26% | 7.36% | 4.75% | 10.66% | 10.45% | 9.77% |
ROE
|
|||
National Health Investors, Inc. peers in Reit Healthcare Facilities
| Company | Market cap | P/E | Compare |
|---|---|---|---|
| LTC LTC Properties, Inc. | $2.3B | 15.7× | Compare |
| SBRA Sabra Healthcare REIT, Inc. | $5.1B | 76.3× | Compare |
| MPT Medical Properties Trust, Inc. | $2.1B | 0.0× | Compare |
| DHC Diversified Healthcare Trust | $2.0B | 0.0× | Compare |
| Company | Market cap | P/E | Compare |
|---|---|---|---|
| HR Healthcare Realty Trust Incorporated | $6.1B | 0.0× | Compare |
| CTRE CareTrust REIT, Inc. | $8.8B | 23.5× | Compare |
| AHR American Healthcare REIT, Inc. | $11.5B | 76.5× | Compare |
| OHI Omega Healthcare Investors, Inc. | $14.0B | 16.4× | Compare |
National Health Investors, Inc. (NHI) key facts
- National Health Investors, Inc. (NHI) is a Reit Healthcare Facilities company in the Real Estate sector, listed on the New York Stock Exchange.
- National Health Investors, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $375.6 million, up 12.1% from fiscal 2024.
- Net income was $140.8 million, or $3.03 per share (basic), a net margin of 37.8%.
- As of September 25, 2026, NHI traded at $66.92, a market capitalization of $3.3 billion.
- At that price the stock trades at 19.3× trailing-twelve-month earnings and 7.5× sales.
- National Health Investors, Inc. pays an annual dividend of $3.60 per share, a yield of 6.82%, with a payout ratio of 142.3%.
- Return on equity was 9.77% and debt-to-equity 0.81.
National Health Investors, Inc. (NHI) Latest News
24 Sep
National Health Investors (NHI) will present at the Bank of America NY Global Real Estate Conference 2026 on September 15 in New York to update investors on its senior housing and medical property portfolio. The stock has softened, down about 8% in the last month and ~13% year-to-date, but three- and five-year total shareholder returns are 54.57% and 63.22%, signaling a longer-term uptrend. Analysts and Simply Wall St flag NHI as undervalued, with a fair value around $82.13 versus a $67.20 close, and point to rising occupancy and RevPOR in its SHOP portfolio and a shift toward outpatient/post-acute care as potential drivers of NOI and rent growth. Risk factors include possible occupancy declines or tenant concentration challenges. Valuation shows a premium vs peers but a discount to a higher fair P/E, leaving potential for multiple expansion if sentiment improves. Upcoming conference updates plus the undervaluation signal could moderately influence sentiment and upside if occupancy and RevPOR trends persist.
19 Aug
National Health Investors held Q2 2026 earnings call discussing quarterly financial results, operations and outlook. Earnings call delivers financial metrics and guidance that shape near-term investor sentiment and performance views.
11 Aug
National Health Investors Inc reported Q2 2026 earnings and outlined a strategic pivot to SHOP. Strategic pivot to SHOP constitutes a major operational shift with potential to significantly alter company trajectory.
National Health Investors Q2 earnings call discussed financial results, operational updates, and outlook for the healthcare REIT. Q2 earnings updates typically influence short-term sentiment without fundamentally shifting long-term trajectory.
National Health Investors, Inc. held its Q2 2026 earnings call covering financial results, operational performance, and outlook. Quarterly earnings calls deliver financial updates that moderately shift near-term market sentiment and valuation.
10 Aug
National Health Investors (NHI) posted Q2 funds from operations below analyst estimates. Q2 FFO shortfall indicates weaker financial results likely to pressure near-term stock performance.
NHI reported second quarter 2026 financial results. Quarterly results update financial metrics that can shift near-term investor views and valuation.
7 Aug
National Health Investors (NHI) appears 12% undervalued with new COO appointment drawing fresh investor interest. New COO hire at NHI sparks market interest that may moderately lift valuation and near-term performance.
1 Jul
NHC completes acquisition of thirty-five NHI facilities. NHI divests thirty-five facilities in major completed transaction.
6 May
National Health Investors, Inc. (NHI) released Q1 2026 earnings call transcript detailing quarterly financial results, operational updates, and forward guidance. Earnings call provides key financial metrics, management insights, and outlook that can drive substantial shifts in investor sentiment and stock trajectory.
5 May
2026 rent resets and activist pressure on National Health Investors (NHI) could recast the bull case for National HealthCare (NHC), potentially reshaping NHI's revenue outlook and strategic direction amid operator relations. Activist pressure combined with 2026 rent resets signals major potential shifts in NHI's financial structure and governance.
National Health Investors, Inc. (NHI) released Q1 2026 earnings call summary highlighting financial results, operational updates, portfolio performance, and forward guidance for the healthcare REIT. Q1 2026 earnings disclosure impacts NHI's financial metrics, occupancy rates, dividend sustainability, and stock valuation.
4 May
National Health Investors (NHI) Q1 FFO and revenues beat analyst estimates. Q1 FFO and revenue beats signal strong financial performance, likely boosting investor sentiment and stock trajectory.
National Health Investors, Inc. (NHI) announced a $106.9 million investment in a SHOP portfolio. $106.9 million SHOP investment expands NHI's senior housing portfolio substantially, driving revenue growth and positive market sentiment.
National Health Investors, Inc. (NHI) Q2 2025 earnings call transcript released, covering quarterly financial results, operational updates, and forward-looking guidance. Quarterly earnings transcripts reveal financial performance, dividend policies, and strategic outlook directly influencing NHI's valuation and investor sentiment.
National Health Investors, Inc. (NHI) released Q1 2025 earnings call transcript detailing quarterly financial results, rental income, occupancy rates, debt management, dividend declarations, and forward guidance. Quarterly earnings disclosures including revenue, FFO, portfolio performance, and outlook directly influence NHI's valuation, investor sentiment, and market trajectory.
National Health Investors, Inc. (NHI) announced first quarter 2026 results. Quarterly earnings announcements affect NHI's financial performance and market sentiment.
26 Apr
Senior housing sector trends are reframing valuation targets for National Health Investors (NHI), highlighting improved prospects amid growing demand. Senior housing narrative shifts are significantly altering NHI's valuation targets and investor sentiment.
22 Apr
National Health Investors, Inc. (NYSE: NHI) plans $560 million sale of 35-property healthcare portfolio to National HealthCare Corporation (NYSE American: NHC), with Blueprint as transaction advisor. The $560 million divestiture of 35 properties is a major strategic move that could reshape NHI's portfolio, liquidity, and investor sentiment.
21 Apr
National HealthCare Corporation (NHC) will acquire 35 facilities from National Health Investors, Inc. (NHI). Divestiture of 35 facilities constitutes a major strategic asset sale impacting NHI's portfolio and future revenue streams.
National Health Investors, Inc. (NHI) announces sale of its NHC portfolio for $560 million. Sale of $560 million NHC portfolio is a major strategic divestiture likely reshaping NHI's balance sheet, liquidity, and investment focus.
18 Apr
Investor attention focuses on National Health Investors (NHI) valuation amid strong income generation and SHOP growth. Income and SHOP growth positively influence NHI's valuation perception and market sentiment.
28 Feb
National Health Investors, Inc. (NHI) Q4 earnings call highlights financial performance, operational updates, portfolio metrics, and forward guidance. Q4 earnings highlights disclose key financials, FFO, occupancy rates, and outlook directly shaping NHI's trajectory and investor sentiment.
27 Feb
National Health Investors, Inc. (NHI) Q4 conference call transcript details quarterly financial results, operational updates, and forward-looking guidance. Q4 conference call transcript discloses earnings results, dividend policy, portfolio updates, and 2024 outlook, significantly impacting investor sentiment and stock trajectory.
National Health Investors Inc (NHI) reported robust growth in Q4 2025 earnings call, highlighting strong financial performance amid challenges. Q4 2025 earnings highlights show robust growth, signaling major positive shifts in NHI's financial trajectory and investor sentiment.
National Health Investors, Inc. released Q4 2025 earnings call summary highlighting financial results, operational updates, and future outlook. Q4 earnings call summary details financial performance and guidance, moderately influencing investor sentiment and stock trajectory.
26 Feb
National Health Investors, Inc. (NHI) announced fourth quarter 2025 results. Quarterly earnings announcements drive significant stock price movements and shape investor expectations for NHI's future performance.
National Health Investors, Inc. (NHI) missed Q4 funds from operations (FFO) estimates. Missing Q4 FFO estimates indicates weaker quarterly financial performance, likely causing moderate short-term pressure on stock price and investor sentiment.
National Health Investors, Inc. (NHI) released its Q4 earnings snapshot, detailing quarterly financial performance. Quarterly earnings snapshots influence financial metrics and short-term market sentiment for NHI.
National Health Investors, Inc. (NHI) issued an investor update detailing operational and financial developments. Investor update from NHI signals moderately noticeable influence on financial performance and market sentiment.